KELSEY JOHNSON: Open Payments
NPI 1407577745 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,794 in 68 payments from 11 companies in 2025. Trend: 2023 $612 · 2024 $568 · 2025 $4,794
Food & beverage: $2,494Honoraria: $2,000Travel & lodging: $223Education: $77
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 8 | $2,532 |
| ABBVIE INC. | 28 | $1,014 |
| Madrigal Pharmaceuticals | 11 | $355 |
| Janssen Biotech, Inc. | 6 | $266 |
| Regeneron Healthcare Solutions, Inc. | 4 | $258 |
| Lilly USA, LLC | 2 | $142 |
| Ardelyx, Inc. | 2 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Celltrion USA Inc. | 2 | $47 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $18 |
Products named: Sucraid, SKYRIZI, REZDIFFRA, TREMFYA, CREON, DUPIXENT, OMVOH, MAVYRET.
Industry payments across KS — which companies pay providers there.
